Liquid biopsy: clearing the barriers to support pharma, labs and patients

There was considerable discussion around liquid biopsy at ASCO 2017 at a time when questions about its clinical utility are still to be addressed. Marianna Sciortino, Associate Director, Diaceutics, assesses the current landscape and looks at the European initiatives aiming to steer the technology clear of the classic adoption barriers.
Existing Users Log In